Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: Pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement

Journal of Thoracic and Cardiovascular Surgery

Volumn 131, Issue 5, 2006, Pages 988-993

  Inoue, Masayoshi ^a   Minami, Masato ^a   Shiono, Hiroyuki ^a   Sawabata, Noriyoshi ^a   Ideguchi, Kan ^a   Okumura, Meinoshin ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; THORACOTOMY; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PLEURA; PLEURAL NEOPLASMS; PNEUMONECTOMY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33646192907     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2005.12.035     Document Type: Article

References (30)

1. Yoshikawa K., Tsubota N., Kodama K., Ayabe H., Taki T., and Mori T. Prospective study of extended segmentectomy for small lung tumors. the final report. Ann Thorac Surg 73 (2002) 1055-1059
2. Koike T., Yamato Y., Yoshiya K., Shimoyama T., and Suzuki R. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg 125 (2003) 924-928
3. Noguchi M., Morikawa A., Kawasaki M., Matsuno Y., Yamada T., Hirohashi S., et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 75 (1995) 2844-2852
4. Okada M., Nishio W., Sakamoto T., Uchino K., Hanioka K., Ohbayashi C., et al. Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas. J Thorac Cardiovasc Surg 127 (2004) 857-861
5. Suzuki K., Asamura H., Kusumoto M., Kondo H., and Tsuchiya R. "Early" peripheral lung cancer. prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 74 (2002) 1635-1639
6. Matsuguma H., Yokoi K., Anraku M., Kondo T., Kamiyama Y., Mori K., et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung. a predictor of lymph node metastasis. J Thorac Cardiovasc Surg 124 (2002) 278-284
7. Nonaka M., Kadokura M., Yamamoto S., Kataoka D., Kunimura T., Kushima M., et al. Tumor dimension and prognosis in surgically treated lung cancer. for intentional limited resection. Am J Clin Oncol 26 (2003) 499-503
8. Asamura H., Suzuki K., Watanabe S., Matsuno Y., Maeshima A., and Tsuchiya R. A clinicopathological study of resected subcentimeter lung cancers. a favorable prognosis for ground glass opacity lesions. Ann Thorac Surg 76 (2003) 1016-1022
9. Pisters K.M.W., and Le Chevalier T. Adjuvant chemotherapy in completely resected non-small-cell lung cancer. J Clin Oncol 23 (2005) 3270-3278
10. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
11. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
12. Cox D.R. Regression models and life-tables. J R Stat Soc [B] 34 (1972) 187-220
13. Birim O., Kappetein A.P., Takkenberg J.J.M., van Klaveren R.J., and Bogers A.J.J.C. Survival after pathological stage IA nonsmall cell lung cancer. tumor size matters. Ann Thorac Surg 79 (2005) 1137-1141
14. Wisnivesky J.P., Yankelevitz D., and Henschke C.I. The effect of tumor size on curability of stage I non-small cell lung cancers. Chest 126 (2004) 761-765
15. Takeda S., Fukai S., Komatsu H., Nemoto E., Nakamura K., and Murakami M. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer. Ann Thorac Surg 79 (2005) 1142-1146
16. Miller D.L., Rowland C.M., Deschamps C., Allen M.S., Trastek V.F., and Pairolero P.C. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg 73 (2002) 1545-1551
17. Sazon D.A., Santiago S.M., Soo Hoo G.W., Khonsary A., Brown C., Mandelkern M., et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 153 (1996) 417-421
18. Guhlmann A., Storck M., Kotzerke J., Moog F., Sunder-Plassmann L., and Reske S.N. Lymph node staging in non-small cell lung cancer. evaluation by [18F]FDG positron emission tomography (PET). Thorax 52 (1997) 438-441
19. Steinert H.C., Hauser M., Allemann F., Engel H., Berthold T., von Schulthess G.K., et al. Non-small cell lung cancer. nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 202 (1997) 441-446
20. Gupta N.C., Tamim W.J., Graeber G.G., Bishop H.A., and Hobbs G.R. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 120 (2001) 521-527
21. Cerfolio R.J., Ojha B., Bryant A.S., Bass C.S., Bartalucci A.A., and Mountz J.M. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg 76 (2003) 861-866
22. Nakata M., Sawada S., Saeki H., Takashima S., Mogami H., Teramoto N., et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg 75 (2003) 1601-1605
23. Yoshida J., Nagai K., Yokose T., Nishimura M., Kakinuma R., Ohmatsu H., et al. Limited resection trial for pulmonary ground-glass opacity nodules. fifty-case experience. J Thorac Cardiovasc Surg 129 (2005) 991-996
24. Sawabata N., Ohta M., Takeda S., Hirano H., Okumura Y., Asada H., et al. Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg 74 (2002) 174-179
25. Okada M., Nishio W., Sakamoto T., Uchino K., Yuki T., Nakagawa A., et al. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer. analysis of 1,000 consecutive resections for clinical stage I disease. Ann Thorac Surg 78 (2004) 216-221
26. Buccheri G., and Ferrigno D. Identifying patients at risk of early postoperative recurrence of lung cancer. a new use of the old CEA test. Ann Thorac Surg 75 (2003) 973-980
27. Sakao Y., Sakuragi T., Natsuaki M., and Itoh T. Clinicopathological analysis of prognostic factors in clinical IA peripheral adenocarcinoma of the lung. Ann Thorac Surg 75 (2003) 1113-1117
28. Takamochi K., Yoshida J., Nishimura M., Yokose T., Sasaki S., Nishiwaki Y., et al. Prognosis and histologic features of small pulmonary adenocarcinoma based on serum carcinoembryonic antigen level and computed tomographic findings. Eur J Cardiothorac Surg 25 (2004) 877-883
29. Shimizu K., Yoshida J., Nagai K., Nishimura M., Ishii G., Morishita Y., et al. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. J Thorac Cardiovasc Surg 130 (2005) 160-165
30. Li M., Ito H., Wada H., and Tanaka F. Pit-fall sign on computed tomography predicts pleural involvement and poor prognosis in non-small cell lung cancer. Lung Cancer 46 (2004) 349-355